Essentially, silencing CCAT1 could downregulate BMI1 in gastric cancer (Li et al., 2018a), whereas miR-218 suppresses the BMI1 expression in hepatocellular carcinoma (Wu et al., 2018). Here, BMI1 is linked to gastric cancer.